Russia’s Global Vaccine Ambitions Stumble During Supply Shortage
- Guatemala latest to report delivery delays of second dose
- Sputnik V overcame doubts on efficacy only to face output woes
This article is for subscribers only.
The Kremlin’s ambitions to win soft-power dividends around the world from Russia’s Covid-19 vaccine are being hampered by delays in delivering Sputnik V to foreign buyers clamoring for supplies.
This week, Guatemalan President Alejandro Giammattei said his country will seek to replace 8 million planned doses with supplies from other producers by the end of year after delays receiving its initial order. Brazil won’t need the 10 million doses of Sputnik it contracted for in March because it had secured other vaccines, Health Minister Marcelo Queiroga said Thursday.